AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46 | -16.4% | 50,633 | -48.3% | 0.00% | -33.3% |
| Q1 2023 | $55 | -99.9% | 97,854 | -25.3% | 0.01% | -14.3% |
| Q1 2022 | $94,000 | -46.3% | 130,949 | +183.0% | 0.01% | -58.8% |
| Q2 2021 | $175,000 | -68.4% | 46,270 | -71.7% | 0.02% | -56.4% |
| Q1 2021 | $554,000 | +167.6% | 163,532 | +98.7% | 0.04% | +8.3% |
| Q3 2020 | $207,000 | +68.3% | 82,303 | +322.3% | 0.04% | +200.0% |
| Q4 2019 | $123,000 | +66.2% | 19,491 | +2.9% | 0.01% | +100.0% |
| Q3 2019 | $74,000 | -52.6% | 18,948 | -32.8% | 0.01% | -25.0% |
| Q4 2018 | $156,000 | +54.5% | 28,181 | +179.1% | 0.01% | +100.0% |
| Q2 2018 | $101,000 | -54.7% | 10,097 | -56.8% | 0.00% | -66.7% |
| Q1 2018 | $223,000 | +21.2% | 23,352 | +88.5% | 0.01% | +20.0% |
| Q4 2017 | $184,000 | -9.8% | 12,387 | +19.4% | 0.01% | 0.0% |
| Q3 2017 | $204,000 | – | 10,372 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
| Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
| Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
| Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
| Ergoteles LLC | 849,000 | $300,000 | 0.01% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |